ArticleScientific reports2020

Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.

Chun-Ting Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.